- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.11. | Sight Sciences auf der Stifel-Konferenz 2025: Zwei Wachstumsmotoren schüren Optimismus | - | Investing.com Deutsch | ||
| 11.11. | Sight Sciences, Inc.: New Peer-Reviewed Publications Highlight Effectiveness of OMNI Surgical System with TruSync Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans | 1 | GlobeNewswire (USA) | ||
| 07.11. | Sight Sciences stock holds steady as Needham maintains rating | 1 | Investing.com | ||
| 07.11. | Sight Sciences raises 2025 revenue guidance to $76M-$78M while accelerating TearCare commercialization | 1 | Seeking Alpha | ||
| 06.11. | Sight Sciences appoints Ali Bauerlein as COO and Jim Rodberg as CFO | 2 | Seeking Alpha | ||
| SIGHT SCIENCES Aktie jetzt für 0€ handeln | |||||
| 06.11. | Sight Sciences appoints new COO and CFO in leadership overhaul | 1 | Investing.com | ||
| 06.11. | Sight Sciences, Inc.: Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer | 65 | GlobeNewswire (Europe) | MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing... ► Artikel lesen | |
| 06.11. | Sight Sciences, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 23.10. | Sight Sciences, Inc.: Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025 | 1 | GlobeNewswire (USA) | ||
| 17.10. | Sight Sciences Shares Jump 32% On Medicare Pricing Update For TearCare System | 1 | RTTNews | ||
| 17.10. | Medicare establishes pricing for Sight Sciences' TearCare System | 1 | Investing.com | ||
| 17.10. | Sight Sciences, Inc.: Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare Interventional Dry Eye Procedure | 1 | GlobeNewswire (USA) | ||
| 17.10. | Sight Sciences, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 30.09. | Sight Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.09. | Sight Sciences reports positive data for Omni surgical system | 1 | MassDevice | ||
| 17.09. | Sight Sciences' OMNI system shows strong results in glaucoma treatment | 1 | Investing.com | ||
| 17.09. | Sight Sciences, Inc.: Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use | 4 | GlobeNewswire (USA) | ||
| 10.09. | Sight Sciences auf Morgan-Stanley-Konferenz: Strategischer Fokus auf Wachstum | - | Investing.com Deutsch | ||
| 09.09. | UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures | 18 | Benzinga.com | ||
| 09.09. | Sight Sciences, Inc.: Sight Sciences Announces the OMNI Surgical System to be Included in UnitedHealthcare's Expanded Coverage of Glaucoma Surgical Treatments | 220 | GlobeNewswire (Europe) | MENLO PARK, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing... ► Artikel lesen |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDLINE | 40,450 | 0,00 % | Aktien New York: Nasdaq schwach nach starkem Jahr - Medline-Börsengang im Blick | NEW YORK (dpa-AFX) - Die US-Börsen haben am Mittwoch erneut nachgegeben. Die Wall Street und vor allem die technologielastige Nasdaq zollten ihrem starken Lauf im Jahr 2025 weiter Tribut. Sorgen über... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,590 | 0,00 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| HEARTBEAM | 3,060 | 0,00 % | Heartbeam stock is a buy, this analyst says | ||
| PROGYNY | 26,010 | 0,00 % | Progyny, Inc. - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 44,390 | -0,56 % | Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers | DJ Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers
DOW JONES--Moody's hat Siemens Healthineers die Bonitätsbewertung A3 gegeben, was als sichere Anlage gilt. Der Ausblick ist... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,160 | -0,35 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,550 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| FRESENIUS | 47,890 | +0,23 % | Fresenius-Aktie im Aufwind: "Neubewertung" erwartet | Die Aktie des Bad Homburger Gesundheitskonzerns Fresenius zählt zum Start in die neue Handelswoche zu den stärksten Werten im deutschen Leitindex. Ein weiteres Lob von Analystenseite sorgt für positive... ► Artikel lesen | |
| BETA BIONICS | 29,200 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 135,46 | 0,00 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| PROCEPT BIOROBOTICS | 33,780 | 0,00 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| RXSIGHT | 12,620 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
| NUTEX HEALTH | 159,17 | 0,00 % | Nutex Health, Inc.: Nutex Health Responds To Short Seller Report | HOUSTON, Nov. 26, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), is aware of a short seller report issued on November... ► Artikel lesen | |
| CLEARPOINT NEURO | 13,550 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,915 | +0,51 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
SIGHT SCIENCES INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 8,140 Euro und damit -2,98 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIGHT SCIENCES INC finden Sie auf Wallstreet Online.